Effect of adjunctive single high-dose vitamin D

Area of Science:

• Pulmonology
• Endocrinology
• Infectious Diseases

Background:

• Low vitamin D status is linked to increased pneumonia risk, severity, and poorer outcomes.
• No prior trials have investigated vitamin D as an adjunctive therapy for community-acquired pneumonia (CAP) in adults.

Purpose of the Study:

• To evaluate the efficacy of adjunctive vitamin D therapy in adults hospitalized with CAP.
• To assess the impact of vitamin D on radiographic infiltrate resolution, hospital stay, and intensive care unit (ICU) admission.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted.
• Participants received a single oral dose of 200,000 IU vitamin D3 or placebo.
• The primary outcome was complete resolution of chest radiograph infiltrate at 6 weeks.

Main Results:

• Adjunctive vitamin D showed no significant effect on the primary outcome (OR 0.78, p=0.548).
• A trend towards improved pneumonia resolution was noted in participants with baseline vitamin D levels <25 nmol/L (OR 17.0, p=0.043), though not statistically significant by exact methods (OR 13.0, p=0.083).
• No significant differences were observed in secondary outcomes, including length of hospital stay or ICU admission.

Conclusions:

• Single-dose adjunctive vitamin D therapy is not effective for improving outcomes in adults with CAP.
• Further research may be warranted to explore potential benefits in specific subgroups, such as those with severe vitamin D deficiency.